Drug intelligence / Profile preview

Monistat-1

Development stage
Unknown
Lead developer
Prestige Consumer Healthcare
Modality
Small Molecules
Administration
Topical, Vaginal
01

Overview

**Monistat-1** is an over-the-counter, single-dose vaginal imidazole-antifungal product line for **vulvovaginal candidiasis**. The primary Monistat 1 Combination Pack contains a 1,200 mg miconazole nitrate vaginal Ovule insert plus 2% miconazole nitrate external vulvar cream; the insert treats the infection and the cream relieves associated external itching and irritation. Miconazole inhibits fungal lanosterol 14-alpha-demethylase, suppressing ergosterol synthesis and compromising fungal cell-membrane integrity. The Monistat 1 name is not fully composition-specific: a Monistat 1 prefilled ointment variant contains tioconazole 6.5% rather than miconazole, although both active ingredients are imidazole antifungals with the same core ergosterol-biosynthesis mechanism. The current Monistat brand is owned by Prestige Consumer Healthcare. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97ff1c90-c250-4921-81af-6a56cc9cc7d2))

Brand names
Monistat 1Monistat1Monistat-1Monistat 1 Combination PackMonistat1 Combination PackMonistat-1 Combination Pack
02

Targets

TUBB (Tubulin (alpha and beta subunits))CYP51A1 (Sterol 14α-demethylase)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Monistat-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monistat-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call